GeneDx Hldgs Q1 2024 Adj EPS $(0.33) Beats $(0.67) Estimate, Sales $62.422M Beat $49.463M Estimate
GeneDx Holdings Corp Ordinary Shares - Class A -0.69% Pre
GeneDx Holdings Corp Ordinary Shares - Class A WGS | 57.79 57.79 | -0.69% 0.00% Pre |
GeneDx Hldgs (NASDAQ:
WGS) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.67) by 50.75 percent. The company reported quarterly sales of $62.422 million which beat the analyst consensus estimate of $49.463 million by 26.20 percent. This is a 44.70 percent increase over sales of $43.139 million the same period last year.